Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
39.75
-17.60 (-30.69%)
At close: Sep 18, 2026, 4:00 PM EDT
39.80
+0.05 (0.13%)
After-hours: Sep 18, 2026, 7:59 PM EDT
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.85 billion as of September 18, 2026. Its market cap has increased by 36.03% in one year.
Market Cap
3.85B
Enterprise Value
2.61B
1-Year Change
36.03%
Ranking
Category
Stock Price
$39.75
ChartMarket Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.85B, an increase of 2,607.04%. That is a compound annual growth rate of 32.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.85B | 11.14% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.46B |
| Telix Pharmaceuticals | 4.31B |
| Relay Therapeutics | 4.13B |
| AbCellera Biologics | 4.09B |
| Celcuity | 3.94B |
| IDEAYA Biosciences | 3.71B |
| Tango Therapeutics | 3.67B |
| Enliven Therapeutics | 3.62B |